These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7799055

  • 1. The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections.
    Moreillon P.
    J Chemother; 1994 Apr; 6 Suppl 2():51-7. PubMed ID: 7799055
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
    Catherall EJ, Irwin R, Mizen LW.
    J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
    Catherall EJ, Irwin R, Mizen L.
    J Chemother; 1989 Jul; 1(4 Suppl):69-70. PubMed ID: 16312308
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New agents for Staphylococcus aureus endocarditis.
    Drees M, Boucher H.
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [Abstract] [Full Text] [Related]

  • 6. Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.
    Kuo CB, Lin JC, Peng MY, Wang NC, Chang FY.
    J Microbiol Immunol Infect; 2007 Aug; 40(4):317-24. PubMed ID: 17712466
    [Abstract] [Full Text] [Related]

  • 7. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK.
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.
    Mehta AP, Phutane L, Patel MH, Rupwate RU, Kamat SR.
    J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F, Fernández-Cuenca F, Pachón-Ibáñez ME, Pascual A, Pichardo C, Martínez-Martínez L, Pachón J.
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J, Kijima K, Kurazono M, Takahata S, Sugano T, Tanaka Y, Hirai Y, Yamada K, Takayama Y, Shitara E, Yonezawa M.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [Abstract] [Full Text] [Related]

  • 12. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
    Al-Shawwa BA, Wegner D.
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY.
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [Abstract] [Full Text] [Related]

  • 15. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B.
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [Abstract] [Full Text] [Related]

  • 16. Development of a mouse model of induced Staphylococcus aureus infective endocarditis.
    Gibson GW, Kreuser SC, Riley JM, Rosebury-Smith WS, Courtney CL, Juneau PL, Hollembaek JM, Zhu T, Huband MD, Brammer DW, Brieland JK, Sulavik MC.
    Comp Med; 2007 Dec; 57(6):563-9. PubMed ID: 18246868
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
    Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.
    Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
    [Abstract] [Full Text] [Related]

  • 19. Novel cephalosporins for the treatment of MRSA infections.
    Glinka TW.
    Curr Opin Investig Drugs; 2002 Feb; 3(2):206-17. PubMed ID: 12020048
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.